The role of reactivation of human herpes virus in drug-induced hypersensitivity syndrome

The role of reactivation of human herpes virus in drug-induced hypersensitivity syndrome - The role of reactivation of human herpes virus in drug-induced hypersensitivity syndrome

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000009709

Enrollment

Registered

2013-01-07

Start date

2013-01-07

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Drug-induced hypersensitivity syndrome

Interventions

Drug-induced hypersensitivity syndrome group Healthy control group

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with drug-induced hypersensitivity syndrome

Exclusion criteria

Exclusion criteria: Patients regarded as inadequate

Design outcomes

Primary

Measure	Time frame
Viral DNA amount and the concentration of cytokine/ chemokine in blood and saliva	—

Countries

Japan

Contacts

Public ContactTomoya Watanabe

Yokohama City University Graduate School of Medicine Environmental Immuno-Dermatology

nabetomo0968@yahoo.co.jp045-787-2675

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026